Top

Reactions Weekly

Published in:

01-06-2023 | Thalassemia | Case report

Luspatercept

Lack of efficacy: case report

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Country of occurrence, reporter country and primary source country not stated.

Manganas KM, et al. THE USE OF LUSPATERCEPT IN PATIENTS WITH B -THALASSAEMIA AND MULTIPLE SYSTEMIC COMPLICATIONS INCREASES HEMOGLOBIN LEVEL, DECREASES TRANSFUSION BURDEN, AND IS UNAFFECTED BY COMPLICATIONS. SINGLE THALASSEMIA AND SICKLE CELL DEPARTEMENT'S EXPERIENCE. HemaSphere 7 (Suppl. 1): 15-16 (plus poster) abstr. 5610224, Apr 2023. Available from: URL: http://doi.org/10.1097/01.HS9.0000928240.02267.88 [abstract]

Title: Luspatercept
Lack of efficacy: case report
Publication date: 01-06-2023
Publisher: Springer International Publishing
Keyword: Thalassemia
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-41914-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Luspatercept

Lack of efficacy: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Rix-4414/rotavirus-w179-9-vaccine

Urofollitropin

Azathioprine/ciclosporin/infliximab

Multiple drugs

Multiple drugs

Amiodarone